NASDAQ:NTRB Nutriband (NTRB) Stock Price, News & Analysis $4.43 +0.26 (+6.24%) (As of 09/6/2024 ET) Add Compare Share Share Today's Range$4.05▼$4.6350-Day Range$4.08▼$9.2552-Week Range$1.53▼$9.60Volume33,895 shsAverage Volume35,356 shsMarket Capitalization$48.89 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrendsStock AnalysisChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends Get Nutriband alerts: Email Address Ad Golden CrestBiden's Successor: The Radical Threat to YOUR Savings!Kamala Harris isn't just playing politics; she's a serious threat to your financial security. Kamala has a plan to take over your money and leave you with nothing. Higher taxes, government control, and a digital dollar to track every penny you spend. This isn't about convenience; it's about CONTROL.>> Get Your FREE Wealth Protection Guide << About Nutriband Stock (NASDAQ:NTRB)Nutriband Inc. develops a portfolio of transdermal pharmaceutical products. Its lead product in development is AVERSA fentanyl, an abuse deterrent fentanyl transdermal system that provides clinicians and patients with an extended-release transdermal fentanyl product for use in managing chronic pain requiring around the clock opioid therapy. The company also develops other products, which include AVERSA buprenorphine and AVERSA methylphenidate; exenatide for type 2 diabetes; and follicle stimulating hormone for infertility. It has a license agreement with Rambam Med-Tech Ltd. for the development of the RAMBAM Closed System Transfer Devices; and Kindeva Drug Delivery, L.P. to develop AVERSAL Fentanyl based on its proprietary AVERSAL abuse deterrent transdermal technology. The company was incorporated in 2016 and is headquartered in Orlando, Florida.Read More NTRB Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart NTRB Stock News HeadlinesSeptember 5 at 8:22 AM | msn.comBioMedNewsBreaks — Nutriband Inc. (NASDAQ: NTRB) Releases Q2 Report, AVERSA Fentanyl UpdateAugust 29, 2024 | msn.comProposed US Law Would Direct Opioid Settlement Cash to Opioid Crisis ManagementSeptember 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…August 1, 2024 | finance.yahoo.comNutriband (NASDAQ:NTRB investor five-year losses grow to 80% as the stock sheds US$27m this past weekJuly 20, 2024 | finanznachrichten.deNutriband, Inc.: Join Nutriband's Exclusive Live Investor Webinar and Q&A Session on July 25May 26, 2024 | finance.yahoo.comNutriband Inc. (NTRB)May 23, 2024 | theglobeandmail.comNutriband (NASDAQ: NTRB) Schedules Live Investor Webinar, Q&A SessionMay 21, 2024 | finance.yahoo.comJoin Nutriband's Exclusive Live Investor Webinar and Q&A Session on May 30September 7, 2024 | Timothy Sykes (Ad)Tim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT about Trump or Biden dropping out of the race…May 16, 2024 | finanznachrichten.deNutriband Inc.: Nutriband Appoints Accomplished Business Leader Sergei Glinka to its Board of DirectorsMay 8, 2024 | theglobeandmail.comNutriband’s (NASDAQ: NTRB) Transdermal Patch with Abuse-Deterrent Tech Funded to Seek FDA ApprovalApril 25, 2024 | finance.yahoo.comIBN Coverage Initiated for Nutriband Inc.April 24, 2024 | finanznachrichten.deNutriband Inc.: Nutriband Closes $8.4M Private Placement for Commercial Development of Aversa Fentanyl Transdermal Patch Through FDA SubmissionApril 24, 2024 | finance.yahoo.comNutriband Closes $8.4M Private Placement for Commercial Development of Aversa(R) Fentanyl Transdermal Patch Through FDA SubmissionApril 21, 2024 | uk.investing.comNutriband closes funding for abuse-deterrent fentanyl patchApril 1, 2024 | finance.yahoo.comNutriband Inc. Begins Manufacturing for Major Sports Brand Licensee Fit for Life Group, Whose Collection of Partnered Brands Include Reebok, Adidas and New BalanceMarch 28, 2024 | marketwatch.comNutriband Shares Rise 30% After Fentanyl Patch Partnership News, Planned FDA SubmissionMarch 27, 2024 | benzinga.comGerald Goodman's Net WorthSee More Headlines Receive NTRB Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Nutriband and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings12/13/2021Today9/07/2024Next Earnings (Estimated)12/10/2024Fiscal Year End1/31/2025Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ SectorMedical Industry Surgical appliances & supplies Sub-IndustryMedical Equipment Current SymbolNASDAQ:NTRB CUSIPN/A CIK1676047 Webnutriband.com Phone(407) 377-6695FaxN/AEmployees10Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.77) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-5,490,000.00 Net Margins-315.56% Pretax Margin-315.56% Return on Equity-71.77% Return on Assets-56.63% Debt Debt-to-Equity Ratio0.03 Current Ratio6.16 Quick Ratio6.04 Sales & Book Value Annual Sales$1.80 million Price / Sales27.10 Cash FlowN/A Price / Cash FlowN/A Book Value$0.73 per share Price / Book6.07Miscellaneous Outstanding Shares11,036,000Free Float6,274,000Market Cap$48.89 million OptionableNot Optionable Beta1.08 The Next 7 Blockbuster Stocks for Growth InvestorsWondering what the next stocks will be that hit it big, with solid fundamentals? Click the link below to learn more about how your portfolio could bloom.Get This Free Report Key ExecutivesMr. Serguei Melnik (Age 50)Founder, President, Company Secretary & Executive Chairman of the Board Comp: $175kMr. Gareth Sheridan (Age 34)Founder, CEO & Director Comp: $175kMr. Gerald Goodman (Age 76)CFO & Chief Accounting Officer Comp: $140kDr. Alan Smith Ph.D. (Age 58)COO & President of 4P Therapeutics Comp: $159kDr. Jeffrey Patrick Pharm.D. (Age 54)Chief Scientific Officer Mr. Michael Myer (Age 39)President of Pocono Pharmaceutical Comp: $40.6kMr. Tyler Overk (Age 40)Head of Active Intelligence More ExecutivesKey CompetitorsReWalk RoboticsNASDAQ:RWLKEyenoviaNASDAQ:EYENConformisNASDAQ:CFMSNevroNYSE:NVRONyxoahNASDAQ:NYXHView All Competitors NTRB Stock Analysis - Frequently Asked Questions How have NTRB shares performed this year? Nutriband's stock was trading at $2.32 at the beginning of 2024. Since then, NTRB stock has increased by 90.9% and is now trading at $4.43. View the best growth stocks for 2024 here. How were Nutriband's earnings last quarter? Nutriband Inc. (NASDAQ:NTRB) announced its quarterly earnings data on Monday, December, 13th. The company reported ($0.12) earnings per share for the quarter, missing the consensus estimate of ($0.02) by $0.11. The company earned $0.28 million during the quarter, compared to the consensus estimate of $0.50 million. Nutriband had a negative net margin of 315.56% and a negative trailing twelve-month return on equity of 71.77%. When did Nutriband's stock split? Nutriband's stock split on the morning of Monday, August 15th 2022. The 13-6 split was announced on Monday, August 15th 2022. The newly created shares were issued to shareholders after the market closes on Monday, August 15th 2022. An investor that had 100 shares of stock prior to the split would have 217 shares after the split. How do I buy shares of Nutriband? Shares of NTRB stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (NASDAQ:NTRB) was last updated on 9/7/2024 by MarketBeat.com Staff From Our PartnersPerfect Crypto Buying Opportunity for 50 CentsWhen cryptos take a hit, the mom and pop investors run for the hills. But the top investors keep buying wit...Crypto 101 Media | SponsoredThe solution to fast food’s wage hike crisisShake Shack will be closing six California locations in response to the recent $20/hour minimum wage increase,...Deal Maker | SponsoredPre-IPO| 32,481% Growth: First Disruption to $martphones in 15 Years🤳45M Users | 32,481% Growth Rate Get in on the biggest disruption to smartphones in over a decade. Reg A inv...Mode Mobile | SponsoredBiden’s Capital Gains Tax to Devastate Savings!Don't let the corrupt elites dictate your future—ACT NOW! This guide is your first step towards financial inde...Golden Crest | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredSay Goodbye to the US DollarThe warning signs are everywhere… According to experts, the United States Dollar is "as good as doomed." ...Sasco Gold LLC | SponsoredChina Stockpiling Gold “Like No Tomorrow”For 18 consecutive months, China’s central bank has increased its gold reserve. The country, with a populat...True Gold Republic | SponsoredMy grim warning about AI stocksToday, I’m warning of another looming catastrophe. Only this time, it’s not in pot stocks, cryptos, or U.S....Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nutriband Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nutriband With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.